OptimizeRx Corp 4
4 · OptimizeRx Corp · Filed Jun 2, 2017
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Harrell David
DirectorChairman of the Board10% Owner
Transactions
- Disposition to Issuer
Common Stock
2017-06-01$0.78/sh−500,000$390,000→ 2,090,750 total
Footnotes (1)
- [F1]The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017.